108 filings
Page 2 of 6
8-K
st2obqg1wlcb p42
5 May 22
Protara Therapeutics Announces First Quarter 2022 Financial Results and Business Overview
8:15am
8-K
z9bxm6ug
9 Mar 22
Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business Overview
7:47am
8-K
gkn84zig
10 Jan 22
Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer
8:23am
8-K
nmqzqw vvc1pqteh21
4 Nov 21
Protara Therapeutics Announces Third Quarter 2021 Financial Results and Business Overview
8:09am
8-K
yor0csf12msf2jw0
18 Oct 21
Departure of Directors or Certain Officers
5:01pm
8-K
x0v 6j9xj
12 Oct 21
Regulation FD Disclosure
7:25am
8-K
wpztj19bbum5
5 Aug 21
Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview
8:01am
8-K
uek3u eq3vf
10 Jun 21
Protara Therapeutics Announces Appointment of Jane Huang, M.D. to Board of Directors
8:11am
8-K
7y5mcqvwq awop
23 Apr 21
Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations
7:01am
8-K
djklv211zf23kz61l7
19 Apr 21
Protara Therapeutics Announces Appointment of MartÃn Sebastian Olivo, M.D. as Chief Medical Officer
4:30pm
8-K
qn3qk
17 Mar 21
Changes in Registrant's Certifying Accountant
5:14pm
8-K
4s7 fs6qa
3 Mar 21
Other Events
8:01am
8-K
noe467d vi
11 Feb 21
Corporate Presentation February 2021
8:01am
8-K
pzk 6yx4sofhq9bhdk7
2 Feb 21
Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors
8:15am
8-K
ro0q1i9wuhyn04u441rt
8 Dec 20
Entry into a Material Definitive Agreement
4:41pm
8-K
azuvc b0eau
7 Dec 20
Departure of Directors or Certain Officers
4:30pm
8-K
dup4zdg3hhs5au7
17 Nov 20
Other Events
9:01am
8-K/A
v3anhu51e 75ghg
8 Oct 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
b9848exl5r2mz
23 Sep 20
Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
9:08am
8-K
8sck0
8 Sep 20
Protara Therapeutics Provides Comparability and U.S. Regulatory Updates for TARA-002 Supporting Advancement in Oncology and Rare Disease Indications
7:15am